Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproate added to standard therapy for glioblastoma
ACTRN12616001350415Phase 4Recruiting
- Sponsor
- Royal Brisbane and Women's Hospital
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of valproic acid in glioblastoma (GBM), sponsored by Royal Brisbane and Women's Hospital. Primary endpoint: F-DOPA and F-MISO PET uptake. Started Jan 2013; status: recruiting.
02
Drugs
valproic acid
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on ACTRN12616001350415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001350415.